Skip to content

Early Diagnosis Model of Colorectal Adenoma Using Laboratory Examinations

Construction and Validation of an Early Diagnosis Model for Colorectal Adenoma Based on Laboratory Examinations

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07793110
Enrollment
400
Registered
2026-08-28
Start date
2026-09-01
Completion date
2028-09-01
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Adenoma, Polyp

Keywords

laboratory tests, Colorectal adenoma, polyp, precancerous lesion

Brief summary

Colorectal cancer has the third highest incidence and second highest mortality rate of all malignant tumors worldwide. Distinct from most other cancers, colorectal cancer can be prevented; colonoscopy-based identification and removal of adenomatous polyps is the most effective preventive measure. Early intestinal adenomas rarely cause specific symptoms, and many patients are diagnosed at advanced stages once symptoms emerge, leading to unsatisfactory treatment and prognosis. Colonoscopy, the main diagnostic tool for intestinal adenoma, is invasive, resulting in limited patient compliance, while grassroots hospitals face shortages of medical resources. There is an urgent demand for a convenient, affordable and well-tolerated early diagnostic method for intestinal adenoma. Artificial intelligence techniques can efficiently analyze routine clinical laboratory data. This study aims to establish an AI-based predictive model combining clinical information and laboratory test results to realize early identification of intestinal adenoma and optimize patient prognosis.

Detailed description

Colorectal cancer ranks the third in incidence and the second in mortality among all malignant tumors, constituting a major global public health concern. Unlike many other malignancies, colorectal cancer is preventable. Early detection and resection of adenomatous polyps via colonoscopy represent the most effective strategy for colorectal cancer prevention. Intestinal adenomas often present without specific clinical symptoms in the early stage. By the time patients seek medical care due to symptomatic manifestations, most have progressed to the middle or advanced stage, which exerts severe adverse impacts on subsequent therapeutic outcomes and long-term survival prognosis. Although colonoscopy serves as the primary modality for the early diagnosis of intestinal adenoma, it is an invasive procedure associated with poor adherence among some patients. In addition, primary medical institutions are constrained by limited medical resources. Accurate and timely early diagnosis of intestinal adenoma is closely linked to targeted clinical intervention and improved patient survival outcomes. Therefore, it is critical to identify an early diagnostic approach for intestinal adenoma that boasts high patient acceptance, low technical barriers, convenience and cost-effectiveness. In recent years, with the advancement and wider accessibility of data analytics tools such as artificial intelligence (AI), growing research efforts have focused on addressing this clinical challenge using AI algorithms. Laboratory testing is routinely performed in clinical practice and delivers timely results, and the massive volume of laboratory data provides evidence supporting early disease diagnosis and prognostic prediction. Advances in artificial intelligence enable clinicians to convert abundant clinical data into practical predictive models to enhance diagnostic performance. Accordingly, integrated analysis of electronic medical records and laboratory results using artificial intelligence facilitates timely detection and early diagnosis of intestinal adenoma, and ultimately improves patient survival prognosis.

Interventions

This is an observational cohort study. No drugs, surgical procedures or therapeutic interventions will be provided to participants. Only routine clinical laboratory and demographic data are collected for constructing and validating a prediction model for colorectal adenoma.

Sponsors

Renmin Hospital of Wuhan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged ≥ 18 years undergoing colonoscopy, with pathologically confirmed diagnosis of colorectal adenoma or non-adenomatous lesions (e.g., inflammatory polyps, hyperplastic polyps, chronic inflammation, etc.); * Capable of reading, understanding and signing the informed consent form; * The investigator judges that the subject can understand the procedures of this clinical study, and is willing and able to cooperate with and complete all study procedures.

Exclusion criteria

* Unavailable clinical data including laboratory test results; * Neoplastic lesions other than colorectal adenoma; * Non-first diagnosis of colorectal adenoma; * Autoimmune diseases; * Repeated enrolled subjects (duplicate patients); * Pregnancy or breastfeeding status; * Failure to obtain informed consent; * The investigator considers that the subject has high-risk diseases or other special conditions unsuitable for participating in this clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Discriminative performance of the clinical prediction model for colorectal adenomaAt the time of colonoscopy enrollmentConstruct an automatic extraction model for laboratory test data and an early colorectal adenoma diagnosis model based on laboratory test results, and prospectively verify the adenoma detection rate among patients stratified by the model into high-risk and low-risk adenoma groups.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026